首页> 外文期刊>Urology >Transperitoneal laparoscopic radical nephrectomy for large (more than 7 cm) renal masses.
【24h】

Transperitoneal laparoscopic radical nephrectomy for large (more than 7 cm) renal masses.

机译:经腹腔镜腹腔镜根治性肾切除术适用于较大(超过7厘米)的肾脏肿块。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To evaluate our laparoscopic radical nephrectomy (LRN) series to determine whether any significant increases have occurred in operative morbidity when resecting large (7 cm or greater) renal masses. LRN is becoming the reference standard for treating suspicious renal masses not amenable to nephron-sparing surgery. METHODS: We retrospectively reviewed the charts of 164 consecutive patients who had undergone laparoscopic radical nephrectomy performed for suspicious renal masses by two surgeons from February 2000 and December 2006. After institutional review board approval, we reviewed the patient charts to determine whether patients with 7-cm or larger lesions had significant differences in age, body mass index, American Society of Anesthesiologists class, operative time, estimated blood loss, conversion rate, positive margin rate, postoperative creatinine, and hematocrit compared with patients with lesions smaller than 7 cm. RESULTS: The data from 164 patients were reviewed. Of these 164 patients, 124 had less than 7-cm masses and 40 had lesions 7 cm or larger. The mean tumor size in the less than 7-cm group was 4.2 cm (range 1.8 to 6.9) and was 9.2 cm (range 7 to 14) in the 7-cm or larger group. The patients with large tumors had a significantly longer operative time, greater estimated blood loss, and increase in postoperative serum creatinine than those with smaller tumors but all other perioperative variables were similar. Two conversions to open radical nephrectomy occurred in both groups. CONCLUSIONS: Our data have clearly shown that larger tumors can safely be resected with transperitoneal laparoscopic nephrectomy. Open nephrectomy for large tumors can be associated with increased morbidity and the use of LRN could minimize this increased risk. Urologists with laparoscopic experience should consider expanding their indication for LRN.
机译:目的:评估我们的腹腔镜根治性肾切除术(LRN)系列,以确定切除大(7 cm或更大)的肾脏肿块时手术发病率是否显着增加。 LRN正在成为治疗不适合进行保肾手术的可疑肾脏肿块的参考标准。方法:我们回顾性回顾了2000年2月至2006年12月由两名外科医生进行的164例因可疑肾脏肿块而进行的腹腔镜根治性肾切除术的患者的病历。在机构审查委员会批准后,我们​​审阅了病历,以确定是否有7-与7厘米以下的病变患者相比,厘米或更大的病变在年龄,体重指数,美国麻醉医师学会等级,手术时间,估计失血量,转化率,阳性切缘率,术后肌酐和血细胞比容方面存在显着差异。结果:回顾了164例患者的数据。在这164例患者中,有124例肿块少于7厘米,有40例病灶在7厘米或更大。小于7厘米组的平均肿瘤大小为4.2厘米(1.8至6.9),而在7厘米或更大的组中为9.2厘米(7至14)。肿瘤较大的患者与肿瘤较小的患者相比,手术时间明显更长,估计失血量更大,术后血清肌酐增加,但所有其他围手术期变量均相似。两组均发生了两次转换为开放性根治性肾切除术。结论:我们的数据清楚地表明,腹腔镜腹腔镜肾切除术可以安全切除较大的肿瘤。对于大肿瘤,开放式肾切除术可能会增加发病率,使用LRN可以最大程度地降低这种增加的风险。具有腹腔镜经验的泌尿科医师应考虑扩大其对LRN的适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号